Table 2 The role of m6A regulators in gastric cancera,b.

From: Role of N6-methyladenosine RNA modification in gastric cancer

Regulator

Role in m6A modification

Function in gastric cancer

Abnormal change

Prognosis

Relevant mechanisms / targets

Reference

METTL3

Writer

Oncogene Promotes GC growth, proliferation, invasion, migration, chemoresistance, angiogenesis, metastasis, and EMT

Upregulated

Poor

METTL3/m6A/SOCS2

METTL3/m6A/YAP1

METTL3/m6A/PBX1/GCH1/BH4

LINC02253/METTL3/m6A/KRT18/MAPK/ERK

miR-4429/METTL3-IGF2BP1/m6A/SEC62

SP1-METTL3-IGF2BP1/m6A/LncRNA THAP7-AS1/PI3K/AKT

METTL3-YTHDF1/m6A/SPHK2/KLF2

ARHGAP5-AS1/METTL3/m6A/ARHGAP5

METTL3-YTHDF1/m6A/PARP1/BER

METTL3-IGF2BP3/m6A/HDGF

METTL3-YTHDF2/m6A/ADAMTS9

METTL3/m6A/HDGF/GLUT4/ENO2

METTL3/m6A/pri-miR17-92/PTEN/TMEM127/AKT/mTOR

HBXIP/METTL3/m6A/MYC

METTL3/m6A/ZMYM1-CtBP-LSD1-CoREST/E-cadherin/EMT

HOXA10/METTL3/m6A/TGFβ/Smad/E-cadherin/EMT

[60]

[61]

[62]

[65]

[66]

[67]

[68]

[69]

[70]

[71]

[72]

[71]

[75]

[76]

[77]

[78]

METTL14

Writer

Oncogene Promotes GC proliferation, invasion, and migration

Suppressor

Inhibits GC growth, proliferation, and invasion

unknown

Downregulated

Poor

Poor

METTL14/m6A/LINC01320/miR-495-5p/RAB19

METTL14/m6A/circORC5/miR-30c-2-3p/AKT1S1

[79]

[80]

WTAP

Writer

Oncogene Promotes GC tumor growth, cell proliferation and Warburg effects

Upregulated

Poor

WTAP/m6A/HK2

[82]

KIAA1429 (VIRMA)

Writer

Oncogene Promotes GC cell aerobic glycolysis

Upregulated

Poor

KIAA1429/m6A/LINC00958/GLUT1

[83]

METTL16

Writer

Oncogene Promotes GC cell proliferation and tumor growth

Upregulated

Poor

METTL16/m6A/cyclinD1

[84]

FTO

Eraser

Oncogene Promotes GC proliferation, invasion, migration, tumor growth and metastasis, mitochondrial metabolism, and cell apoptosis

Upregulated

Poor

HDAC3/FOXA2/FTO/m6A/MYC

FTO/m6A/HOXB13/PI3K/AKT/mTOR

PPI/FTO/m6A/mTORC1/DDIT3

FTO/m6A/caveolin-1

[85]

[86]

[90]

[87]

ALKBH5

Eraser

Oncogene Promotes GC proliferation, invasion, and metastasis

Upregulated

Poor

ALKBH5/m6A/lncRNA NEAT1/EZH2

ALKBH5-LncRNA NRON/m6A/NANOG

[91]

[92]

Suppressor Inhibits GC invasion and migration

Downregulated

Improved

ALKBH5/m6A/PKMYT1

[93]

YTHDC2

Reader

Oncogene Promotes GC progression

Upregulated

Poor

YTHDC2/m6A/YAP/YTHDC2 Positive feedback loop

[94]

YTHDF1

Reader

Oncogene Promote GC proliferation, invasion, tumorigenesis, and lung metastasis

Upregulated

Poor

YTHDF1/m6A/USP14

YTHDF1/m6A/FZD7/Wnt/β-catenin

[95]

[46]

YTHDF2

Reader

Suppressor Inhibits GC proliferation, invasion, and migration

Downregulated

Improved

YTHDF2/m6A/FOXC2

[96]

IGF2BP1

Reader

Oncogene Promotes GC proliferation, migration, and aerobic glycolysis

Upregulated

Poor

IGF2BP1-METTL3/m6A/SEC62

IGF2BP1/m6A/c-MYC

[66]

[98]

IGF2BP2

Reader

Oncogene Promotes GC proliferation and migration

Upregulated

Poor

IGF2BP2/m6A/SIRT1

IGF2BP2/m6A/IGF1R/RhoA-ROCK

[99]

[100]

IGF2BP3

Reader

Oncogene Promotes GC invasion and migration

Upregulated

Poor

IGF2BP3/m6A/PKMYT1

[93]

  1. aThe role of m6A regulators which function in gastric cancer in an m6A-dependent manner is summarized.
  2. bM6A regulators affect the progression of gastric cancer through the MYC pathway, Hippo pathway, MAPK/ERK pathway, PI3K/AKT/mTOR pathway, mTORC1 pathway, Wnt/β-catenin pathway, EMT pathway, and apoptosis pathway.
  3. GC gastric cancer, EMT epithelial-mesenchymal transition.